Home BusinessAarti drugs up on capex plans
Aarti Drugs closed at Rs 108, higher by Rs 2 or 2.8%, on the BSE.
- Ashok Leyland gains on Dec sales jump - Sensex slips 75pts amid lacklustre trade - Sensex ends down 75 pts - Maha Govt blocks moneycontrol.com, bseindia.com for its staff - Another lacklustre day - Kalpataru Power advances on winning orders
The stock opened at Rs 87, which also happened to be the day"s low, and a high of Rs 111 during the day.
A total of 1.76 lakh shares were traded on the BSE as against the two-week average of 0.55 lakh shares.
-----------------------------------------------------------------------------------(Updated at 0956am)
Aarti Drugs has gained in morning trades on plans of expansion.
The stock jumped 4% to touch a high of Rs 109. The stock is currently trading at Rs 107 - up 2%. Around 7,908 shares have been trded on the BSE so far.
The company is considering a proposal for capital expenditure aggregating up to Rs 40 crore by way of expansion and acquisition. The capex will be funded by external commercial borrowing.